TTRX — Turn Therapeutics Balance Sheet
0.000.00%
- $107.89m
- $104.70m
Annual balance sheet for Turn Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | R2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 2.1 | 1.18 |
| Prepaid Expenses | ||
| Total Current Assets | 2.13 | 1.2 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0.081 | 0.033 |
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 2.91 | 2.01 |
| Payable / Accrued | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 1.72 | 0.49 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 1.76 | 1.93 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 1.16 | 0.086 |
| Total Liabilities & Shareholders' Equity | 2.91 | 2.01 |
| Total Common Shares Outstanding |